A detailed history of Pitcairn CO transactions in Haleon PLC stock. As of the latest transaction made, Pitcairn CO holds 178,503 shares of HLN stock, worth $1.71 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
178,503
Previous 279,381 36.11%
Holding current value
$1.71 Million
Previous $2.9 Million 44.74%
% of portfolio
0.13%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$8.72 - $10.35 $879,656 - $1.04 Million
-100,878 Reduced 36.11%
178,503 $1.6 Million
Q2 2025

Aug 18, 2025

BUY
$9.27 - $11.41 $2.34 Million - $2.88 Million
252,828 Added 952.16%
279,381 $2.9 Million
Q2 2025

Aug 14, 2025

SELL
$9.27 - $11.41 $2.65 Million - $3.27 Million
-286,400 Reduced 91.52%
26,553 $275,000
Q1 2025

May 09, 2025

BUY
$9.02 - $10.67 $334,687 - $395,910
37,105 Added 13.45%
312,953 $3.22 Million
Q4 2024

Feb 12, 2025

BUY
$9.23 - $10.71 $236,851 - $274,829
25,661 Added 10.26%
275,848 $2.64 Million
Q3 2024

Nov 12, 2024

BUY
$8.32 - $10.7 $158,787 - $204,209
19,085 Added 8.26%
250,187 $2.65 Million
Q2 2024

Aug 13, 2024

BUY
$8.01 - $8.64 $454,078 - $489,792
56,689 Added 32.5%
231,102 $1.91 Million
Q1 2024

May 13, 2024

BUY
$8.02 - $8.67 $483,758 - $522,965
60,319 Added 52.87%
174,413 $1.48 Million
Q4 2023

Feb 14, 2024

BUY
$7.78 - $8.62 $279,504 - $309,682
35,926 Added 45.96%
114,094 $938,000
Q3 2023

Nov 13, 2023

BUY
$7.85 - $8.94 $318,027 - $362,186
40,513 Added 107.59%
78,168 $651,000
Q2 2023

Jul 09, 2024

SELL
$8.04 - $9.0 $1.06 Million - $1.19 Million
-132,359 Reduced 75.89%
42,054 $352 Million
Q2 2023

Aug 11, 2023

BUY
$8.04 - $9.0 $302,746 - $338,895
37,655 New
37,655 $315,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Pitcairn CO Portfolio

Follow Pitcairn CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.